Capital Market Strategies’s Bristol-Myers Squibb BMY Stock Holding History

Capital Market Strategies’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,133	Closed	-$200K	–	143
2023 Q2	$200K	Buy	+3,133	New	+$210K	0.19%	135
2022 Q3	–	Sell	-2,639	Closed	-$203K	–	137
2022 Q2	$203K	Buy	+2,639	New	+$201K	0.21%	130

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital Market Strategies's BMY Position: Q3 2023 in Review

Capital Market Strategies sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,133 shares — an estimated $200K sold.

Capital Market Strategies first reported a position in BMY in Q2 2022 and held it in 2 quarters. The position peaked at $203K in Q2 2022. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Capital Market Strategies reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
Capital Market Strategies sold 3,133 Bristol-Myers Squibb shares in Q3 2023, an estimated $200K.
Capital Market Strategies first reported a position in Bristol-Myers Squibb in Q2 2022 and held it in 2 quarters.
Capital Market Strategies's Bristol-Myers Squibb position peaked at $203K in Q2 2022.
2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Capital Market Strategies's 13F filing for Q3 2023, filed 18 Oct 2023.